Overview

Insulin Analogues and Severe Hypoglycaemia

Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
Severe hypoglycaemia is hampering the lives of many diabetic patients. The effect on the occurrence of severe hypoglycaemia during two different insulin regimens are to be investigated. In total, 250 hypoglycaemia prone type 1 diabetic patients will be randomised to receive analogue and human insulin for one year in random order. Outcomes will be number of episodes of severe hypoglycaemia
Phase:
Phase 4
Details
Lead Sponsor:
Lise Tarnow
Collaborator:
Novo Nordisk A/S
Treatments:
Insulin
Insulin Detemir
Insulin, Globin Zinc
Insulin, Isophane
Isophane insulin, beef
Isophane Insulin, Human